AG
AMRX icon

Algert Global’s Amneal Pharmaceuticals AMRX Stock Holding History

Algert Global’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-355,929
Closed -$4.42M – 1243
2026
Q1 		$4.42M Sell
355,929
-25,910
-7% -$348K 0.07% 473
2025
Q4 		$4.81M Sell
381,839
-568,299
-60% -$6.5M 0.08% 450
2025
Q3 		$9.51M Sell
950,138
-90,926
-9% -$816K 0.16% 203
2025
Q2 		$8.42M Buy
1,041,064
+480,281
+86% +$3.62M 0.18% 172
2025
Q1 		$4.7M Buy
560,783
+114,788
+26% +$958K 0.12% 298
2024
Q4 		$3.53M Sell
445,995
-2,211
-0.5% -$18.5K 0.08% 405
2024
Q3 		$3.73M Sell
448,206
-4,518
-1% -$35.3K 0.1% 347
2024
Q2 		$2.87M Buy
452,724
+46,537
+11% +$295K 0.1% 349
2024
Q1 		$2.46M Buy
406,187
+99,637
+33% +$562K 0.1% 343
2023
Q4 		$1.86M Buy
306,550
+62,950
+26% +$280K 0.07% 436
2023
Q3 		$1.03M Buy
243,600
+54,040
+29% +$202K 0.05% 565
2023
Q2 		$588K Sell
189,560
-77,242
-29% -$165K 0.03% 779
2023
Q1 		$371K Sell
266,802
-63,656
-19% -$127K 0.02% 896
2022
Q4 		$658K Buy
330,458
+110,590
+50% +$248K 0.04% 723
2022
Q3 		$444K Sell
219,868
-17,293
-7% -$48.5K 0.03% 839
2022
Q2 		$754K Sell
237,161
-54,898
-19% -$199K 0.06% 594
2022
Q1 		$1.22M Buy
292,059
+190,866
+189% +$845K 0.08% 437
2021
Q4 		$485K Sell
101,193
-87,844
-46% -$438K 0.06% 549
2021
Q3 		$1.01M Buy
189,037
+86,177
+84% +$434K 0.13% 222
2021
Q2 		$527K Buy
102,860
+55,870
+119% +$318K 0.18% 181
2021
Q1 		$316K Buy
+46,990
New +$260K 0.1% 290
2020
Q1 		– Sell
-129,020
Closed -$622K – 410
2019
Q4 		$622K Buy
129,020
+64,630
+100% +$225K 0.19% 179
2019
Q3 		$187K Buy
+64,390
New +$225K 0.07% 284

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Algert Global's AMRX Position: Q2 2026 in Review

Algert Global sold out of Amneal Pharmaceuticals (AMRX) in Q2 2026, closing a stake of 355,929 shares — an estimated $4.42M sold.

Algert Global first reported a position in AMRX in Q3 2019 and held it in 23 quarters. The position peaked at $9.51M in Q3 2025. 306 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Algert Global reported no remaining Amneal Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Algert Global sold 355,929 Amneal Pharmaceuticals shares in Q2 2026, an estimated $4.42M.
  • Algert Global first reported a position in Amneal Pharmaceuticals in Q3 2019 and held it in 23 quarters.
  • Algert Global's Amneal Pharmaceuticals position peaked at $9.51M in Q3 2025.
  • 306 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.